Navigation Links
Experts Lay to Rest Long-Held Misconceptions About High Fructose Corn Syrup at ILSI-USDA Workshop
Date:4/27/2009

Corresponding Journal of Nutrition supplement urges health professionals to help reduce consumer confusion

WASHINGTON, April 27 /PRNewswire/ -- A supplement to be published in the June issue of the Journal of Nutrition encourages the scientific community and the general public to stop demonizing high fructose corn syrup as the culprit of obesity and to rethink the myths about high fructose corn syrup's impact on the American diet.

"The State of the Science on Dietary Sweeteners Containing Fructose" is the scientific summary of a joint conference held in March 2008 by the International Life Sciences Institute of North America and the U.S. Department of Agriculture, Agricultural Research Service. Several scientific papers from the supplement are currently available online.

The conference brought together several scientific leaders from varying backgrounds, including former critics of high fructose corn syrup, who found there is little evidence that high fructose corn syrup and sugar (or sucrose) have differing effects on satiety, overall energy balance, metabolic hormones or biochemical metabolites such as triglycerides and uric acid - all suggesting no unique causal role for high fructose corn syrup in obesity.

According to Suzanne P. Murphy, Ph.D., R.D., research professor at the Cancer Research Center of Hawaii, University of Hawaii, noted in her summary of the presented papers, "...[high fructose corn syrup] and sucrose are similar and one is not 'better or worse' than the other."

Dr. Murphy notes that "it does not appear to be practical to base dietary guidance on selecting or avoiding these specific types of sweeteners."

High Fructose Corn Syrup Is Not the Same as Fructose

Confusion about high fructose corn syrup has been fueled in part by erroneous links to research testing high levels of pure fructose,
'/>"/>

SOURCE Corn Refiners Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Global health experts release new guidance on malaria elimination
2. For ST-Elevation Myocardial Infarction (STEMI), Interviewed Experts Indicate That The Medicines Companys Angiomax/Angiox Has Efficacy Advantages Over Sales-Leading ReoPro
3. Media Advisory: PHR Experts Available to Comment on Torture
4. Surveyed Experts Indicate That the Combination of Sutent and Taxol Has Advantages Over the Combination of Avastin and Taxol in the Treatment of Metastatic Triple-Negative Breast Cancer
5. PAREXEL Experts to Address Partnering Best Practices and Innovative Trial Design at Partnerships With CROs Conference
6. Beauty-Doctors Website Provides Dermatologist-Authored Skin Care Information from Experts
7. For Atrial Fibrillation, Surveyed Experts Indicate That Multaq, Celivarone and ATI-2042 Have Advantages Over Propafenone in the Maintenance of Normal Sinus Rhythm
8. Experts Highlight Inroads to Preventing Cancer
9. PRA International to Present Key Challenges for Safety Professionals at the World Drug Safety Congress: PRA Experts discussing REMS at Washington DC Conference
10. For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission
11. National Health Experts Launch Bipartisan Coalition to Fight Chronic Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... ( http://www.vaginalmeshlawsuit2015.com/ ) in the U.S. District Court, Southern District ... against C.R. Bard, Inc. in that proceeding’s first bellwether trial. ... defense request for a new trial after finding that C.R. ...
(Date:1/22/2015)... has released a new blog post explaining the main features ... , Auto insurance quotes help many drivers find the best ... call an agent or visit an agency for price information. ... http://autocarinsurancebest.com/ . , Every business who relies heavily on ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... January 22, 2015 Four years since the release ... which coincided with the marriage of Avasa & Matthew Love – ... which is scheduled for release through White Swan Records on February ... there is a sacred path available to all of us to ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 JJsHouse.com is a ... dresses. Today, the business announces its latest collection of ... , “The most important issue is the wedding dress on ... thing in a woman’s life. Every bride wants to find ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2
... MD The Endocrine Society,s 91st Annual Meeting, ENDO 09 ... Center in Washington, DC, June 10-13, 2009. Approximately 7,500 ... expected to assemble for this premier meeting of hormone ... an opportunity for journalists to learn about the latest ...
... possible, transplanting stem cells from the patient,s own bone marrow is ... , The procedure has been tested successfully in the ... shown in 80% of cases, and considerable improvement in quality of ... Clnic has used this therapy in a total of 6 patients. ...
... RiskAnalyzer Incorporates Johns Hopkins ACG System for Provider ... Ala., Feb. 19 ... its new Medicare risk adjustment software, DSTHS RiskAnalyzer(TM). ... coding is not capturing disease conditions under the ...
... hospital clients received unexpected checks totaling nearly $4.4 ... from $65,000 to more than $750,000 - were ... unique and innovative partnership between the hospital management ... the QHR/Gallagher Retro Insurance Program, hospital groups that ...
... correlate relationship with the invasion and metastasis of ... N-cadherin may promote motility and invasion in carcinoma ... and N-cadherin expressions in esophageal squamous cell carcinoma ... Fan from China detected the expression of E-cadherin ...
... Roughly 100,000 Swedes are under treatment with the blood-thinning ... which makes the initiation of treatment a risky balancing ... at Uppsala University have developed a model for calculating ... appears in the scientific publication New England Journal ...
Cached Medicine News:Health News:News media registration opens for ENDO 09 in Washington, D.C. 2Health News:New therapy with stem cells to treat Crohn's disease 2Health News:New therapy with stem cells to treat Crohn's disease 3Health News:New therapy with stem cells to treat Crohn's disease 4Health News:New therapy with stem cells to treat Crohn's disease 5Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 2Health News:DST Health Solutions Launches New RiskAnalyzer Software to Help Medicare Advantage Plans Manage Risk Adjustment 3Health News:QHR, Gallagher Partnership Yields More Thank $4 Million for QHR Hospital Clients 2Health News:Knowledge of genetics improves uncertain medication 2
(Date:1/23/2015)... 2015 Gem Pharmaceuticals announced today that the initial ... the Company,s Phase 2 clinical trial.  This open-label study ... compound, GPX-150 (an investigational medication), in approximately 30 adults ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... BOULDER, Colo. , Jan. 22, 2015  BiOptix is ... Klakamp as Vice President of Chemistry and Biochemistry. Scott ... Takeda Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course ... and development. "Scott is a nationally recognized ...
(Date:1/22/2015)... AMGN ) today announced that it will report its ... 27, 2015, after the close of the U.S. financial markets. The ... community at 2 p.m. PT. Participating in the call from Amgen ... officer, and other members of Amgen,s senior management team. ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2
... The Institute for Health Protection (IHP), in partnership with ... and Jefferson State Community College, will host a free community ... from 9 a.m. to 2 p.m. To register for the ... The program will focus on education, prevention and ...
... 27 Mylan Inc. (Nasdaq: MYL ) today ... motion for an interim injunction pending an on-going appeal of ... Paroxetine CR. The New Jersey District Court previously denied Mylan,s ... decision will now continue before the Third Circuit. Mylan is ...
Cached Medicine Technology:Free Diabetes Health Program Saturday, Oct. 30 at Jefferson State Community College 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: